Relay Therapeutics
Relay Therapeutics develops cancer drugs using computer simulations of protein motion, so its link to computing demand is indirect, placing it among third-order compute beneficiaries.
Checked against the company's own business description in its latest annual filing.
Latest disclosed
10-Q filed 2026-08-06 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.